Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects

Carcinogenesis

Volumn 24, Issue 6, 2003, Pages 1097-1103

  Zijno, A ^a   Andreoli, C ^a,d   Leopardi, P ^a   Marcon, F ^a   Rossi, S ^a   Caiola, S ^a   Verdina, A ^b   Galati, R ^b   Cafolla, A ^c   Crebelli, R ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Ente Tabacchi Italiano   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BIOLOGICAL MARKER; CYANOCOBALAMIN; DNA; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE;

ADULT; AGE; CANCER RISK; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; FEMALE; FOLIC ACID BLOOD LEVEL; GENDER; GENETIC DAMAGE; GENOTOXICITY; GENOTYPE; HUMAN; LYMPHOCYTE; MALE; METHYLATION; MICRONUCLEUS; PRIORITY JOURNAL; REVIEW; VITAMIN BLOOD LEVEL;

EID: 0038687702     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg064     Document Type: Review

References (51)

1. Tomatis,L., Huff,J., Hertz-Picciotto,I., Sandler,D.P., Bucher,J., Boffetta,P., Axelson,O., Blair,A., Taylor,J., Stayner,L., and Barrett,J.C. (1997) Avoided and avoidable risks of cancer. Carcinogenesis, 18, 97-105.
2. Ames,B.N. (2001) DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat. Res., 475, 7-20.
3. Scott,J.M. (1999) Folate and vitamin B12. Proc. Nutr. Soc., 58, 441-448.
4. Fenech,M. (2001) The role of folic acid and vitamin B12 in genomic stability of human cells. Mutat. Res., 475, 51-67.
5. Ballestar,E. and Esteller,M. (2002) The impact of chromatin in human cancer: linking DNA methylation to gene silencing. Carcinogenesis, 23, 1103-1109.
6. Rodriguez,M.J., Lopez,M.A., Garcia-Orad,A. and Vig,B.K. (2001) Sequence of centromere separation: effect of 5-azacytidine-induced epigenetic alteration. Mutagenesis, 16, 109-114.
7. Choi,S.W. and Mason,J.B. (2000) Folate and carcinogenesis: an integrated scheme. J. Nutr., 130, 129-132.
8. Blount,B.C., Mack,M.M., Wehr,C.M., MacGregor,J.T., Hiatt,R.A., Wang,G., Wickramasinghes,S.N., Everson,R.B. and Ames,B.N. (1997) Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci., 94, 3290-3295.
9. Fenech,M., Dreosti,I.E. and Rinaldi,J. (1997) Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men. Carcinogenesis, 18, 1329-1336.
10. Fenech,M., Aitken,C. and Rinaldi,J. (1998) Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis, 19, 1163-1171.
11. Duthie,S.J. and Hawdon,A. (1998) DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J., 12, 1491-1497.
12. Crott, J.W., Mashiyama, S.T., Ames, B.N. and Fenech, M. (2001) The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol. Biomarkers. Prev. 10, 1089-1096.
13. Leclerc,D., Wilson,A., Dumas,R., Gafuik,C., Song,D., Watkins,D., Heng,H.H., Rommens,J.M., Scherer,S.W., Rosenblatt,D.S. and Gravel,R.A. (1998) Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc. Natl. Acad. Sci. USA, 95, 3059-3064.
14. Hobbs,C.A., Sherman,S.L., Yi,P., Hopkins,S.E., Torfs,C.P., Hine,R.J., Pogribna,M., Rozen,R. and James,S.J. (2000) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am. J. Hum. Genet., 67, 623-630.
15. O'Leary, V.B., Parle-McDermott,A., Molloy,A.M., Kirke,P.N., Johnson,Z., Conley,M., Scott,J.M. and Mills,J. (2002) L. MTRR and MTHFR polymorphism: link to Down syndrome? Am. J. Med. Genet. 107, 151-155.
16. Wilson,A, Platt,R., Wu,Q., Leclerc,D., Christensen,B., Yang,H., Gravel,R.A. and Rozen,R. (1999) A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol. Genet. Metab., 67, 317-323.
17. Ma,J., Stampfer,M.J., Giovannucci,E., Artigas,C., Hunter,D.J., Fuchs,C., Willett,W.C., Selhub,J., Hennekens,C.H. and Rozen,R. (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res., 57, 1098-1102.
18. Slattery,M.L., Potter,J.D., Samowitz,W., Schaffer,D. and Leppert,M. (1999) Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol. Biomarkers Prev., 8, 513-518.
19. Skibola,C.F., Smith,M.T., Kane,E., Roman,E., Rollinson,S., Cartwright,R.A. and Morgan,G. (1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl. Acad. Sci. USA, 96, 12810-12815.
20. Wiemels,J.L., Smith,R.N., Taylor,G.M., Eden,O.B., Alexander,F.E. and Greaves,M.F. (2001) Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc. Natl. Acad. Sci. USA, 98, 4004-4009.
21. Frosst,P., Blom,H.J., Milos,R., Goyette,P., Sheppard,C.A., Matthews,R.G., Boers,G.J., den Heijer,M., Kluijtmans,L.A., van den Heuvel,L.P. et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 10, 111-113.
22. Miao,X., Xing,D., Tan,W., Qi,J., Lu,W. and Lin,D. (2002) Susceptibility to gastric cardia adenocarcinoma. and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk chinese population. Cancer Epidemiol. Biomarkers Prev., 11, 1454-1458.
23. Crott,J.W., Mashiyama,S.T., Ames,B.N. and Fenech,M. (2001) Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro. Carcinogenesis, 22, 1019-1025.
24. Carere,A., Andreoli,C., Galati,R., Leopardi,P., Marcon,F., Rosati,M.V., Rossi,S., Tomei,F., Verdina,A., Zijno,A. and Crebelli,R. (2002) Biomonitoring of exposure to urban air pollutants: analysis of sister chromatid exchanges and DNA lesions in peripheral lymphocytes of traffic policemen. Mutat. Res., 518, 215-224.
25. Verdina,A., Galati,R., Falasca,G., Ghittori,S., Imbriani,M., Tomei,F., Marcellini,L., Zijno,A., Vecchio,V.D. and Crebelli R. (2001) Metabolic polymorphisms and urinary biomarkers in subjects with low benzene exposure. J. Toxicol. Environ. Health A, 64, 607-618.
26. Olteanu,H., Munson,T. and Banerjee,R. (2002) Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry, 41, 13378-13385.
27. Benesch,R.E., Benesch,R., Kwong,S. and Baugh,C.M. (1983) A pteroylpolyglutamate binds to tetramers in deoxyhemoglobin but to dimers in oxyhemoglobin. Proc. Natl. Acad. Sci. USA, 80, 6202-6205.
28. Leopardi,P., Zijno,A., Marcon,F., Conti,L., Carere,A., Verdina,A., Galati,R., Tomei,F., Baccolo,T.P. and Crebelli,R. (2003) Analysis of micronuclei in peripheral blood lymphocytes of traffic wardens. Effects of exposure, metabolic genotypes, and inhibition of excision repair in vitro by Ara-C. Environ. Mol. Mutagen. 41, 126-130.
29. Fenech,M. (1993) The cytokinesis-block micronucleus technique a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res., 285, 35-44.
30. Singh,N.P., McCoy,M.T., Tice,R.R. and Schneider,E.L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175, 184-191.
31. Andreoli,C., Leopardi,P. and Crebelli,R. (1997) Detection of DNA damage in human lymphocytes by alkaline single cell gel electrophoresis after exposure to benzene or benzene metabolites. Mutat. Res., 377, 95-104.
32. Cafolla,A., Dragoni,F., Girelli,G., Tosti,M.E., Costante,A., Pastorelli,D., Bedogni,G. and Scott,S. (2000) Folate status in Italian blood donors: relation to gender and smoking. Haematologica, 85, 694-698.
33. Fermo,I., Vigano',D.S., Paroni,R., Mazzola,G., Calori,G. and D'Angelo,A. (1995) Prevalence of moderate hyperhomocysteinemia in patients with early- onset venous and arterial occlusive disease. Ann. Intern. Med., 123, 747-753.
34. Silva,A.E., Manzato,A.J. and Varella-Garcia,M. (1992) Sister-chromatid exchanges in beta-thalassaemic patients under conditions of in vivo and in vitro depletion of folic acid. Mutat. Res., 282, 213-217.
35. Gollapudi,B.B., Sutcliffe,D.J. and Sinha,A.K. (1986) Assessment of cytogenetic response to folic, acid deprivation in rat lymphocytes. In vitro Cell Dev. Biol., 22, 681-684.
36. Denissenko,M.F., Pao,A., Tang,M. and Pfeifer,G.P. (1996) Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots. Science, 274, 430-432.
37. Gurdal-Yuksel,E., Karadag,M., Ozyardimci,N., Kunt-Uzaslan,A.E. and Yarkin,T. (1996) Cigarette smoking, serum lipids, folate, and vitamin B12 in lung cancer. J. Environ. Pathol. Toxicol. Oncol., 15, 161-167.
38. Hartman,T.J., Woodson,K., Stolzenberg-Solomon,R., Virtamo,J., Selhub,J., Barrett,M.J. and Albanes,D. (2001) Association of the B-vitamins pyridoxal 5′-phosphate (B(6)), B(12), and folate with lung cancer risk in older men. Am. J. Epidemiol., 153, 688-694.
39. Breneman,J.W., Briner,J.F., Ramsey,M.J., Director,A. and Tucker,J.D. (1996) Cytogenetic results from a chronic feeding study of MeIQx in mice. Food Chem. Toxicol., 34, 717-724.
40. Director,A.E., Nath,J., Ramsey,M.J., Swiger,R.R. and Tucker,J.D. (1996) Cytogenetic analysis of mice chronically fed the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine. Mutat. Res., 359, 53-61.
41. Nishikawa,A., Furukawa,F., Miyauchi,M., Son,H.Y., Okazaki,K., Koide,A., Mori,Y. and Hirose,M. (2002) Enhancement by cigarette smoke exposure of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis in close association with elevation of hepatic CYP1A2. Jpn. J. Cancer Res., 93, 24-31.
42. Mori,Y., Koide,A., Kobayashi,Y., Furukawa,F., Hirose,M. and Nishikawa,A. (2003) Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver. Mutagenesis, 18, 87-93.
43. Ehrlich,M. (2002) DNA methylation in cancer: too much, but also too little. Oncogene, 21, 5400-5413.
44. Duthie,S.J., Narayanan,S., Brand,G.M., Pirie,L. and Grant,G. (2002) Impact of folate deficiency on DNA stability. J. Nutr., 132, 2444S-2449S.
45. Hakimi,M.A., Bochar,D.A., Schmiesing,J.A., Dong,Y., Barak,O.G., Speicher,D.W., Yokomori,K. and Shiekhattar,R. (2002) A chromatin remodelling complex that loads cohesin onto human chromosomes. Nature, 418, 994-998.
46. Bernardino-Sgherri,J., Chicheportiche,A., Niveleau,A. and Dutrillaux,B. (2002) Unusual chromosome cleavage dynamic in rodent neonatal germ cells. Chromosoma, 111, 341-347.
47. Robertson,K.D. and Jones,P.A. (2000) DNA methylation: past, present and future directions. Carcinogenesis, 21, 461-467.
48. Choi,S.W. and Mason,J.B. (2002) Folate status: effects on pathways of colorectal carcinogenesis. J. Nutr., 132, 2413S-2418S.
49. Stern,L.L., Mason,J.B., Selhub,J. and Choi,S.W. (2000) Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomarkers. Prev., 9, 849-853.
50. Friso,S., Choi,S.W., Girelli,D., Mason,J.B., Dolnikowski,G.G., Bagley,P.J., Olivieri,O., Jacques,P.F., Rosenberg,I.H., Corrocher,R. and Selhub,J. (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. USA, 99, 5606-5611.
51. Crott,J.W. and Fenech,M. (2001) Preliminary study of the genotoxic potential of homocysteine in human lymphocytes in vitro. Mutagenesis, 16, 213-217.